These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8429342)

  • 1. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction.
    Nedelman MA; Shealy DJ; Boulin R; Brunt E; Seasholtz JI; Allen IE; McCartney JE; Warren FD; Oppermann H; Pang RH
    J Nucl Med; 1993 Feb; 34(2):234-41. PubMed ID: 8429342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An instant kit method for labeling antimyosin Fab' with technetium-99m: evaluation in an experimental myocardial infarct model.
    Pak KY; Nedelman MA; Kanke M; Khaw BA; Mattis JA; Strauss HW; Dean RT; Berger HJ
    J Nucl Med; 1992 Jan; 33(1):144-9. PubMed ID: 1730981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction.
    Khaw BA; Mattis JA; Melincoff G; Strauss HW; Gold HK; Haber E
    Hybridoma; 1984; 3(1):11-23. PubMed ID: 6469268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
    Milenic DE; Yokota T; Filpula DR; Finkelman MA; Dodd SW; Wood JF; Whitlow M; Snoy P; Schlom J
    Cancer Res; 1991 Dec; 51(23 Pt 1):6363-71. PubMed ID: 1933899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial distribution of indium-111-antimyosin Fab and technetium-99m-sestamibi in experimental nontransmural infarction.
    Morguet AJ; Munz DL; Klein HH; Pich S; Conrady A; Nebendahl K; Kreuzer H; Emrich D
    J Nucl Med; 1992 Feb; 33(2):223-8. PubMed ID: 1531070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers.
    Khaw BA; Klibanov A; O'Donnell SM; Saito T; Nossiff N; Slinkin MA; Newell JB; Strauss HW; Torchilin VP
    J Nucl Med; 1991 Sep; 32(9):1742-51. PubMed ID: 1880577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of isothiocyanatobenzyl-DTPA derivatized monoclonal antimyosin fab for enhanced in vivo target localization.
    Khaw BA; Gansow O; Brechbiel MW; O'Donnell SM; Nossiff N
    J Nucl Med; 1990 Feb; 31(2):211-7. PubMed ID: 2313361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of cardiac transplantation rejection in primates using two new antimyosin agents.
    Vaccarino RA; Sanchez JE; Johnson LL; Wang TS; Seldin DW; Marboe C; Egbe P; Bhatia K; Rose EA; Khaw BA
    J Nucl Med; 1992 Nov; 33(11):1994-9. PubMed ID: 1432161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate.
    Khaw BA; Strauss HW; Moore R; Fallon JT; Yasuda T; Gold HK; Haber E
    J Nucl Med; 1987 Jan; 28(1):76-82. PubMed ID: 3025386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary roles of antibody affinity and specificity for in vivo diagnostic cardiovascular targeting: how specific is antimyosin for irreversible myocardial damage?
    Khaw BA; Petrov A; Narula J
    J Nucl Cardiol; 1999; 6(3):316-23. PubMed ID: 10385187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of myocardial infarct detection using Tc99m pyrophosphate and In111 DTPA antimyosin (R11D10 Fab).
    Cox PH; Schonfeld D; Remme WF; Pillay M; Brons R
    Int J Card Imaging; 1987; 2(3):197-8. PubMed ID: 2828484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18-antimyosin monoclonal antibody fragments: preliminary investigations in a canine myocardial infarct model.
    Zalutsky MR; Garg PK; Johnson SH; Utsunomiya H; Coleman RE
    J Nucl Med; 1992 Apr; 33(4):575-80. PubMed ID: 1552343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
    Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab.
    Khaw BA; Yasuda T; Gold HK; Leinbach RC; Johns JA; Kanke M; Barlai-Kovach M; Strauss HW; Haber E
    J Nucl Med; 1987 Nov; 28(11):1671-8. PubMed ID: 3668661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
    Khawli LA; Alauddin MM; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of cardiac myosin-specific antibody in myocardial infarction.
    Khaw BA; Beller GA; Haber E; Smith TW
    J Clin Invest; 1976 Aug; 58(2):439-46. PubMed ID: 956377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of early necrosis in a canine model of low flow myocardial ischemia using 125I-antimyosin (Fab')2.
    Timmis AD; Lopez JA; Fallon JT; Khaw BA; Haber E; Powell WJ
    J Appl Cardiol; 1987; 2(3):185-211. PubMed ID: 11540157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of myocardial infarct size before and after reperfusion: dual-tracer imaging with radiolabeled antimyosin antibody.
    Narula J; Nicol PD; Southern JF; Pieri P; O'Donnell SM; Guererro JL; Nossiff ND; Newell JB; Strauss HW; Khaw BA
    J Nucl Med; 1994 Jun; 35(6):1076-85. PubMed ID: 8195873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
    George AJ; Jamar F; Tai MS; Heelan BT; Adams GP; McCartney JE; Houston LL; Weiner LM; Oppermann H; Peters AM
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8358-62. PubMed ID: 7667295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.